Hydralazine Hydrochloride
NDC 71610-562, Hydralazine Hydrochloride, tablet, from Aphena Pharma Solutions - Tennessee, LLC.
- Product NDC
- 71610-562
- Status
- Listed
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA205236
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/71610-562 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- HYDRALAZINE HYDROCHLORIDE50 mg/1
Pharmacologic classes
Arteriolar Vasodilation [PE]; Arteriolar Vasodilator [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 71610-562-60 | 71610056260 | 90 TABLET in 1 BOTTLE (71610-562-60) |
| 71610-562-80 | 71610056280 | 180 TABLET in 1 BOTTLE (71610-562-80) |
| 71610-562-92 | 71610056292 | 270 TABLET in 1 BOTTLE (71610-562-92) |
| 71610-562-98 | 71610056298 | 540 TABLET in 1 BOTTLE (71610-562-98) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/c2638ae6-a210-490f-8389-bbed6a3229c5
Use it
Look up 71610-562 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/71610-562 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 71610-562. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.